Apr 28, 2001|
Indian ADRs: Holding out
After having rallied significantly earlier in April, the US markets seem to be taking a breather with profit booking having set in. The rally has drawn mixed reactions, with some labeling it a dead cat bounce. Others believe that the worst is probably over. So far in April, the Dow has gained 13.6% and the NASDAQ 16.3%.
Indian ADRs posted a mixed performance, on the back of the sharp gains recorded last week. While Infy logged in gains, ICICI Bank was a significant loser. The fall in ICICI Bank can in part be attributed to the rumored losses the company has suffered in its capital markets operations (lending to brokers). Infy on the other hand appeared to be stabilizing at existing levels after its much publicized warning earlier this month.
Rediff too has been among the prominent losers. This was because the company reported lower than expected growth in turnover. For the year ended March 2001 Rediff reported nearly 140% growth in revenues and reduced its loss for the period by 4% to US$ 6.4 m. However, Rediff saw some heavy spurts during the week as most analysts had still recommended a buy on this Indian ADR.
New entrant Dr. Reddy however, continued its steady climb. The pharma major has been continually stating that it will continue to focus on Research and Development of new molecules for clinical trials.
However, over the past week as the NASDAQ fell over 4%, Indian tech ADRs counters led by Infosys gained. Though Indian tech majors are expected to show a slowdown in growth, a lot of these companies are still expected to sustain a healthy grow rate. The same may not be the case for a lot of US technology companies. Though it may be too early to say this, but it sure looks like a sign that the investors are now segregating their buying actions based on regional factors.
Given the slowdown in both the Indian and US economies a sustained recovery in the Indian ADRs (especially the TMT stocks) seems to be unlikely. Added to that Sebiís recommendations on ban of carry forward transactions will also impede a recovery of the Indian bourses, atleast in the short term.
More Views on News
Jun 14, 2017
Should you subscribe to the IPO of Tejas Networks Ltd?
May 26, 2017
Don't be surprised to come across some Super Investors there!
May 19, 2017
Not all small-cap investors see themselves as traders. Some see themselves as business owners.
Jul 31, 2017
Should you subscribe to the IPO of Securities & Intelligence Services Ltd?
Jul 8, 2017
If Super Investors can wait for the right pitch, so can you.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 4, 2017
The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407